What is NDC 81962-001?

81962-001 is the product NDC for Meropenem, Meropenem 1 g/20mL injection, listed with the FDA by BROOKS STERISCIENCE LIMITED. It has 3 package NDCs, shown above in 10- and 11-digit form.

BROOKS STERISCIENCE LIMITED, NDC labeler code 81962. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Meropenem?

42 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Meropenem NDC 81962-001 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)81962-001Labeler and product segments. Claims need a package NDC.

Product NDC at billing width81962-0001Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
81962-001-01	8196200010181962000101	1 VIAL in 1 CARTON (81962-001-01) / 20 mL in 1 VIALMarketed from May 31, 2023
81962-001-02	8196200010281962000102	10 VIAL in 1 CARTON (81962-001-02) / 20 mL in 1 VIALMarketed from May 31, 2023
81962-001-03	8196200010381962000103	25 VIAL in 1 CARTON (81962-001-03) / 20 mL in 1 VIALMarketed from May 31, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Meropenem
Generic name (nonproprietary): meropenem
Active ingredients: Meropenem — 1 g/20mL
Dosage form: Injection
Route: Intravenous
Labeler: BROOKS STERISCIENCE LIMITEDNDC labeler code 81962
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216154
Marketing start: May 31, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Carbapenems (Chemical structure)
Identifiers: Product ID 81962-001_4caa1d3a-1dba-7392-e063-6294a90a0080SPL ID 4caa1d3a-1dba-7392-e063-6294a90a0080SPL set ID 58e165b7-e230-4459-abf9-06d5ca1dd7b2RxCUI 1722934, 1722939UNII FV9J3JU8B1UPC 0381962000018, 0381962001022
Pharmacologic class: Penem Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N481962000101 followed by a unit qualifier and the quantity

Package 81962-0001-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 31, 2025.

Indications (excerpt from the label)

Meropenem for Injection is a penem antibacterial indicated for the treatment of: • Complicated skin and skin structure infections (adult patients and pediatric patients 3 months of age and older only). (1.1) • Complicated intra-abdominal infections (adult and pediatric patients). (1.2) • Bacterial meningitis (pediatric patients 3 months of age and older only). (1.3) To reduce the development of drug-resistant bacteria and maintain the effectiveness of Meropenem for Injection and other antibacterial drugs, Meropenem for Injection should only be used to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. 1.1 Complicated Skin and Skin Structur…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 81962-001

What is NDC 81962-001?: 81962-001 is the product NDC for Meropenem, Meropenem 1 g/20mL injection, listed with the FDA by BROOKS STERISCIENCE LIMITED. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Meropenem.
What is the active ingredient?: Meropenem.
Who is the labeler?: BROOKS STERISCIENCE LIMITED, NDC labeler code 81962. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Meropenem?: 42 other product NDCs are listed under this name. See all Meropenem NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Meropenem NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Meropenem	Meropenem 500 mg/10mL	Injection, Powder, For solutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9485	00143-9485-10
Meropenem	Meropenem 1 g/20mL	Injection, Powder, For solutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9486	00143-9486-10
Meropenem	Meropenem 500 mg/20mL	Injection, Powder, For solutionIntravenous	Sagent Pharmaceuticals	25021-160	25021-0160-20
Meropenem	Meropenem 1 g/30mL	Injection, Powder, For solutionIntravenous	Sagent Pharmaceuticals	25021-161	25021-0161-30
Meropenem	Meropenem 1 g/20mL	InjectionIntravenous	Civica, Inc.	72572-410	72572-0410-10
Meropenem	Meropenem 500 mg/20mL	InjectionIntravenous	Civica, Inc.	72572-412	72572-0412-10
Meropenem	Meropenem anhydrous 2 g/1	InjectionIntravenous	Mylan Institutional LLC	72078-081	72078-0081-06
Meropenem	Meropenem anhydrous 2 g/1	InjectionIntravenous	BROOKS STERISCIENCE LIMITED	81962-002	81962-0002-08
Meropenem	Meropenem 500 mg/20mL	InjectionIntravenous	Qilu Antibiotics Pharmaceutical Co., Ltd.	51810-502	51810-0502-02
Meropenem	Meropenem 1 g/30mL	InjectionIntravenous	Qilu Antibiotics Pharmaceutical Co., Ltd.	51810-503	51810-0503-02

All 43 Meropenem NDCs

Other NDCs under ANDA 216154

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216154
Product	Strength	Form · route	Labeler	Product NDC
Meropenem	Meropenem 500 mg/20mL	InjectionIntravenous	ARMAS PHARMACEUTICALS INC	72485-411
Meropenem	Meropenem 1 g/20mL	InjectionIntravenous	ARMAS PHARMACEUTICALS INC	72485-412
Meropenem	Meropenem 1 g/20mL	InjectionIntravenous	Civica, Inc.	72572-410
Meropenem	Meropenem 500 mg/20mL	InjectionIntravenous	Civica, Inc.	72572-412
Meropenem	Meropenem 500 mg/20mL	InjectionIntravenous	BROOKS STERISCIENCE LIMITED	81962-000